Sanofi

In News

Sanofi MS drug rejected in US gets an endorsement in Europe - BioPharma Dive

BioPharma Dive - Apr 24, 2026

Sanofi’s immunology reckoning; Lilly acquires in vivo CAR-T biotech; RevMed’s ‘Herceptin moment’; and more - Endpoints News

Endpoints News - Apr 25, 2026

Sanofi Strengthens Vaccine and Specialty Care Portfolio With New Nuvaxovid Data and Multiple April 2026 Approvals - TipRanks

TipRanks - Apr 27, 2026

Regulatory round-up: Novartis, Sanofi and Arrowhead secure CHMP blessings - Yahoo Finance

Yahoo Finance - Apr 24, 2026

Sanofi gets some good news for BTK inhibitor tolebrutinib, as EU body backs approval - FirstWord Pharma

FirstWord Pharma - Apr 24, 2026

Sanofi MS drug gets positive review in Europe following FDA - statnews.com

statnews.com - Apr 24, 2026

Sanofi gains long-awaited win for tolebrutinib as EU regulator endorses MS drug for approval - Fierce Pharma

Fierce Pharma - Apr 24, 2026

Sanofi CFO defends Hudson’s Dupixent legacy, but accepts ‘number of setbacks’ in R&D - Fierce Biotech

Fierce Biotech - Apr 23, 2026

With Dupixent driving growth, Sanofi touts 'vigorous defense' to extend US exclusivity - Fierce Pharma

Fierce Pharma - Apr 23, 2026

Sanofi's solid earnings set stage for new CEO after drug trial 'setbacks' - Reuters

Reuters - Apr 23, 2026

Sanofi (SNY) scores key FDA approvals and EU CHMP nods across pipeline - Stock Titan

Stock Titan - Apr 27, 2026

Earnings call transcript: Sanofi’s Q1 2026 earnings beat forecasts, stock rises - Investing.com

Investing.com - Apr 23, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment